Inmune Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Inmune Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
  • Inmune Bio, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $193K.
  • Inmune Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.19M, a 1020% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $193K +$228K Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q3 2023 -$35K Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q1 2022 -$1.6M -$425K -$417K -5213% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$1.19M -$641K -$646K -12920% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-03
Q3 2021 -$541K -$437K -$540K -524% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-03
Q2 2021 -$1K -$101K -$100K -10000% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $99K -$8K -$30K -136% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $129K $5K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $103K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$1K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $22K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.